Personal Drug Importation Fairness Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 7, 2017)
Personal Drug Importation Fairness Act of 2017
This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.
What just happenedFeb 10, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 7, 2017
- Feb 10, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 7, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 7, 2017IntroReferralIntro-H
Introduced in House
- Feb 7, 2017IntroReferral1000
Introduced in House